Dr. Petrocca is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
830 Harrison Ave
Boston, MA 02118Phone+1 857-284-2515- Is this information wrong?
Education & Training
Sapienza University of RomeClass of 2004
Certifications & Licensure
MA State Medical License 2020 - 2025
Publications & Presentations
PubMed
- 976 citationsAnti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple MyelomaNoopur Raje, Jesus G. Berdeja, Yi Lin, David S. Siegel, Sundar Jagannath
The New England Journal of Medicine. 2019-05-01 - 173 citationsBiallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma.Mehmet Kemal Samur, Mariateresa Fulciniti, Anil Aktas Samur, Abdul Hamid Bazarbachi, Yu-Tzu Tai
Nature Communications. 2021-02-08 - 22 citationsIdecabtagene vicleucel for relapsed and refractory multiple myeloma: post hoc 18-month follow-up of a phase 1 trial.Yi Lin, Noopur S Raje, Jesús G Berdeja, David S Siegel, Sundar Jagannath
Nature Medicine. 2023-09-01
Journal Articles
- Idecabtagene Vicleucel in Relapsed and Refractory Multiple MyelomaNikhil C Munshi, Larry D Anderson, Deepu Madduri, Sagar Lonial, Noopur Raje, Fabio Petrocca, Kristen Hege, The New England Journal of Medicine
Press Mentions
How Boston Is Beating CancerJanuary 24th, 2023- BMC Is Poised to Enter the CAR T-cell Therapy Clinical Trials EcosystemJanuary 12th, 2023
Hospital Affiliations
Boston Medical CenterBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
